- recruiting
Post-Market Celect Platinum Vena Cava Filter and Gunther Tulip Retrieval Set Study
This study looks at how well a device called a Celect Platinum Vena Cava Filter works over time. This filter helps stop blood clots from reaching your lungs. Researchers want to make sure it's safe and effective for patients with blood clot issues.
United States · Spain · United Kingdom - active not recruiting
Outcomes of Patients Who Survived Treatment on an Intensive Care Unit for COVID-19 in England and Wales
This study looks at the health of people in England and Wales one year after they left intensive care for COVID-19. Researchers will compare their health to people who were in intensive care for other reasons. The aim is to understand long-term health effects.
United Kingdom - recruitingPHASE3
RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing
This study compares two medicines, rivaroxaban and LMWH, for preventing blood clots in people with leg injuries needing a cast or brace. It aims to see if rivaroxaban is as good as, and easier to use than, LMWH for those at higher risk of clots.
France - authorisedTherapeutic exploratory (Phase II)
Colchicine to Quench the Inflammatory Response after Deep Vein Thrombosis: The CONQUER-DVT Randomized Controlled Trial
This study looks at whether a drug called colchicine can help prevent long-term problems like pain, swelling, and discomfort (Post-Thrombotic Syndrome) after a deep vein thrombosis (DVT). Researchers are comparing colchicine tablets to a dummy tablet.
Italy - not yet recruitingNA
Microvisk Continuous Blood Donation Study
This study is helping to develop new blood test strips for people taking warfarin. These strips aim to make regular checks on your blood clotting easier and more accurate. Your blood samples will help improve these new tests.
United Kingdom - recruitingNA
GEKO Venous Thromboembolism Prevention Study
This study compares two ways to prevent blood clots (VTE) in stroke patients who can't move much. It looks at the standard treatment (IPC) versus a new device called geko™ to see which works better over three months.
United Kingdom